Clinical Trial

Hybrid Early Intervention for Infants at Risk of Cerebral Palsy

Recruiting
View on ClinicalTrials.gov →
Summary
This study aimed to evaluate the feasibility, safety, and caregiver acceptance of the Homeostasis-Enrichment-Plasticity (HEP®) Approach, a novel early intervention based on the environmental enrichment paradigm, applied as a hybrid model for infants at risk for cerebral palsy (CP). The effects on functional goals, development, and parental well-being will be examined. The intervention consists of weekly one-hour sessions for 12 weeks with 17 infants aged 4-10 months at risk for CP, identified via the Prechtl Assessment or brain imaging. Feasibility and acceptance will be assessed by a 24-item Likert scale. Developmental outcomes will be measured with GAS, Bayley-III, ISFT, and DASS-21.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-04; most recent amendment 2025-11-13.
Trial Details
NCT Number NCT07116148
Lead Sponsor Medipol University
Conditions Cerebral Palsy (CP)
Enrollment 22 participants
Start Date 2025-09-05
Primary Completion 2025-11 (estimated)
Study Completion 2025-11 (estimated)
Updated on ClinicalTrials.gov 2025-11-14